NCT04628767 trial: what clinicians have said so far
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
- NCT04628767 ↗
- Recruiting
- National Cancer Institute (NCI)
- Focused size, estimated: 1–150 verified statements once built
Discussed at: 2026 ASCO Genitourinary Cancers Symposium
We haven't built an HCP commentary report on NCT04628767 yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on NCT04628767 so far
Podcasts, YouTube videos and posts on X and Bluesky we have indexed that name the trial. LinkedIn posts are read for reports and the Enterprise MCP, not yet for this index. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Indexed so far | |
|---|---|
| 3 posts on X, typically up to 13 once built |
The trial
ClinicalTrials.gov- Official title
- A Phase II/III Trial of Durvalumab and Chemotherapy for Patients With High Grade Upper Tract Urothelial Cancer Prior to Nephroureterectomy
- Phase
- Phase 2/Phase 3
- Status
- Recruiting
- Conditions
- Renal Pelvis and Ureter Urothelial Carcinoma
- Interventions
- Biopsy Procedure; Biospecimen Collection; Cisplatin; Computed Tomography; Doxorubicin Hydrochloride; Durvalumab; Gemcitabine Hydrochloride; Magnetic Resonance Imaging; Methotrexate; Pegfilgrastim; Therapeutic Conventional Surgery; Vinblastine Sulfate
- Arms
- Arm A (durvalumab, chemotherapy) · Experimental
- Arm B (chemotherapy) · Active comparator
- Arm C (durvalumab, gemcitabine hydrochloride) · Experimental
- Enrollment
- 131 (estimated)
- Primary outcomes
- Event-free survival (EFS) (Cisplatin eligible cohort: Arms A and B)
- Pathologic complete response (pCR) (Cisplatin ineligible cohort: Arm C)
- Sponsor
- National Cancer Institute (NCI)
- Start
- Nov 12, 2021
- Primary completion
- Sep 30, 2027 (estimated)
- Results posted
- No
- Registry record
- NCT04628767 · updated Nov 18, 2026